UCAR Logo

UCAR

A nonprofit consortium of universities advancing atmospheric and Earth system sciences.

ALUCR | PA

Overview

Corporate Details

ISIN(s):
FR0011070457
LEI:
969500K8EPT7JBE7FP45
Country:
France
Address:
10 RUE LOUIS PASTEUR, 92100 BOULOGNE-BILLANCOURT

Description

The University Corporation for Atmospheric Research (UCAR) is a nonprofit consortium of over 120 member colleges and universities dedicated to advancing the atmospheric and related Earth system sciences. UCAR manages the National Science Foundation National Center for Atmospheric Research (NSF NCAR) and serves as a hub for the scientific community. It provides access to advanced research facilities, observing and computing resources, data and software services, and educational programs. The organization accelerates scientific discoveries and offers opportunities like internships, fellowships, and workshops to support students, early-career scientists, and established professionals.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2021-07-05 18:00
Ucar - Bilan semestriel du contrat de liquidité
French 253.8 KB
2021-06-25 18:00
Descriptif du programme de rachat d'Actions
French 111.5 KB
2021-06-25 18:00
Compte rendu Assemblée Générale du 22 juin 2021
French 184.1 KB
2021-06-07 19:00
Ucar nombre d'actions et droits de vote au 31 mai 2021
French 121.1 KB
2021-06-07 19:00
UCAR avis de convocation AGM 22 juin 2021
French 157.9 KB
2021-05-12 17:45
UCAR - Avis de réunion AG 22 juin 2021
French 349.5 KB
2021-05-03 18:00
Ucar nombre d'actions et de droits de vote au 30 avril 2021
French 121.8 KB
2021-04-27 20:10
UCAR RAPPORT ANNUEL 2020
French 1.5 MB
2021-04-27 20:10
UCAR Resultats 2020
French 192.1 KB
2021-04-03 12:00
Ucar nombre d'actions et de droits de vote au 31 mars 2021
French 122.0 KB
2021-03-04 18:00
Ucar nombre d'actions et de droits de vote au 28 février 2021
French 122.0 KB
2021-02-25 00:00
UCAR Chiffre d'affaires au 31 décembre 2020
French 198.8 KB
2021-02-10 18:00
Ucar Erratum nombre d'actions et de droits de vote au 31 janvier 2021
French 122.4 KB
2021-02-09 18:00
Ucar nombre d'actions et de droits de vote au 31 janvier 2021
French 123.0 KB
2021-02-01 19:00
Informations complémentaires suite à une cyberattaque
French 132.4 KB

Automate Your Workflow. Get a real-time feed of all UCAR filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for UCAR

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for UCAR via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.